SCHEMBL17429651

SCHEMBL17429651

COC(=O)c1ccc(CCCc2cc(C)cc(C)c2)c(B2OC(C)(C)C(C)(C)O2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP4A11 Q02928 4/20 0.38
▸ CYP4F2 P78329 3/20 0.37
▸ UCHL1 P09936 1/20 0.37
▸ MAPT P10636 3/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ CXCR2 P25025 4/20 0.34
▸ RAB9A P51151 3/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ ALOX12 P18054 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ CKS1B P61024 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17418052 0.93 UCHL1 (0.40) CYP4A11CYP4F2UCHL1MAPTTDP1
SCHEMBL17429646 0.91 CYP4A11 (0.45) CYP4A11CYP4F2MAPTKDM4ERAB9A
SCHEMBL17429652 0.88 UCHL1 (0.33) CYP4A11UCHL1MAPTKDM4ETDP1
SCHEMBL17429645 0.84 TDP1 (0.35) UCHL1MAPTKDM4ETDP1CXCR2
SCHEMBL28607176 0.83 UCHL1 (0.39) UCHL1KDM4ECA1CA2
SCHEMBL17386132 0.83 MTNR1A (0.45) CYP4A11CYP4F2RAB9AMEN1KMT2A
SCHEMBL17429672 0.82 UCHL1 (0.36) CYP4A11CYP4F2UCHL1MAPTKDM4E
SCHEMBL18362455 0.82 CXCR2 (0.39) CYP4A11CYP4F2UCHL1MAPTKDM4E
SCHEMBL23795687 0.81 UCHL1 (0.41) UCHL1MAPTKDM4ETDP1RAB9A
SCHEMBL17429702 0.81 CXCR2 (0.35) CYP4A11CYP4F2UCHL1CXCR2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9643946-B2 Tricyclic compound and use thereof SK CHEMICALS CO., LTD. (KR) 2017-05-09 — — US disclosed
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF SK CHEMICALS CO., LTD. (KR) 2016-01-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF GPR65, GPR119, GPR35 CYP4A11 159/4885CYP4F2 958/4885UCHL1 4494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback